The Scientist


Most Recent

image: Contributors


By | October 1, 2016

Meet some of the people featured in the October 2016 issue of The Scientist


image: Curious George

Curious George

By | October 1, 2016

George Church has consistently positioned himself at genomics’ leading edge.

1 Comment

image: Gene Editing: From Roots to Riches

Gene Editing: From Roots to Riches

By | October 1, 2016

Advances in genetic manipulation have simplified the once daunting task of rewriting a gene.


image: Thirty Years of Progress

Thirty Years of Progress

By | October 1, 2016

Since The Scientist published its first issue in October 1986, life-science research has transformed from a manual and often tedious task to a high-tech, largely automated process of unprecedented efficiency.

1 Comment

image: Targeting the Noncoding Genome with CRISPR

Targeting the Noncoding Genome with CRISPR

By | September 29, 2016

Two independent groups demonstrate the utility of CRISPR-based techniques to identify regulatory elements that govern disease-linked genes. 

1 Comment

image: Monsanto Buys Rights to CRISPR

Monsanto Buys Rights to CRISPR

By | September 27, 2016

The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.


image: Another CRISPR Biotech Goes Public

Another CRISPR Biotech Goes Public

By | September 12, 2016

CRISPR Therapeutics, the company started by a pioneer of the gene editing technology, plans to raise $90 million from an initial public offering.


Tips on how to surmount the challenges of working with CRISPR to manipulate genes in human stems cells to study their function in specific diseases or to correct genetic defects in patient cells.

1 Comment

image: CRISPR: No Cutting Required

CRISPR: No Cutting Required

By | August 4, 2016

Combining a modified Cas9 enzyme with an unrelated one derived from the immune system of the sea lamprey, researchers demonstrate yet another way to edit a single DNA nucleotide. 


image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.


Popular Now

  1. HIV Spread from Haiti to NYC in 1970, “Patient Zero” Not to Blame
  2. Culprit for Antibody Blockade Identified
  3. Investigation Finds Pathologist Guilty of Systemic Misconduct
  4. Many Evolutionary Paths Lead to Same Bird Trait